osimertinib,lazertinib,amivantamab
janssen,astrazeneca,yuhan corp
['sclc', 'amivantamab', 'nsclc', 'lung', 'lazertinib', 'osimertinib', 'astrazeneca', 'janssen']
want to know more about new partners in egfr-mutated lung cancer? pasi janne from will be speaking on neoadjuvant osimertinib and amivantamab + lazertinib in the post-osimertinib setting today at #asco23! s406 at 1pm #nsclc 
Creating Aha! Moments In Healthcare
IDEOlogy Health is leading the change in how HCPs stay up-to-date.